Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015- Appointment of Ms. Divya Mittal as an Additional Director in Category of Non-Executive Independent Director of Company.

20th August, 2026 BSE Limited Corporate Relationship Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 BSE Scrip Code: 540416 Sub: Appointment of Independent Director Reg. Disclosure under Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 30 read with Para A, Part A, Clause 7 of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we hereby inform you that the Board of Directors of Octaware Technologies Limited (“the Company”), at its meeting held on 17th August, 2026, based on the recommendation of the Nomination and Remuneration Committee, has appointed Ms Divya Mittal (DIN: 11902340) as an Additional Director in the category of Non-Executive Independent Director of the Company. The appointment is effective for a first term of five consecutive years, i.e., from 20th August, 2026 to 19th August, 2031, subject to the approval of the shareholders of the Company. Ms Divya Mittal is not liable to retire by rotation. She has provided the requisite declarations and confirmations, including confirmation of meeting the criteria of independence under the applicable provisions of the Companies Act, 2013 and the SEBI LODR Regulations. Further, based on the declaration furnished by Ms Divya Mittal, we confirm that she is not debarred from holding the office of director by virtue of any order of SEBI or any other authority and is not disqualified from holding the office of director under Section 164 of the Companies Act, 2013. The details required under Regulation 30 of the SEBI LODR Regulations are enclosed as Annexure The meeting was concluded at 4.30 PM. This is for your information and records please. Yours Sincerely, Thanking you For Octaware Technologies Limited Mohammed Aslam Qudratullah Khan Managing Director DIN: 00016438 Annexure-A Disclosure under Regulation 30 of the SEBI LODR Regulations: Sl Particulars Details 1. Name Divya Mittal 2. DIN DIN: 11902340 3. Designation Additional Director in the category of Non-Executive Independent Director 4. Reason for change viz. appointment, Appointment as an Additional Director in re-appointment, resignation, the category of Non-Executive removal, death or otherwise Independent Director 5. Date of appointment/ 20th August, 2026 reappointment/cessation (as applicable) & term of appointment / re-appointment 6. Term of appointment First term of five consecutive years from 20th August, 2026 to 19th August, 2031, subject to shareholders’ approval 7. Brief profile Divya Mittal holds an MBA in Marketing, B.Sc. Biology, and B.Ed. She has training experience with Aventis Pharma and HCL Infosys. Divya Mittal is a marketing and HR professional with 20+ years of experience, mainly in pharmaceutical and healthcare companies. She currently manages HR, sales and marketing at Dr. Fresh Assets Ltd. Previously, she worked with Pfizer India, Cipla, and Innovex India in sales, marketing, team management, and training roles. 8. Disclosure of Relationships between Nil Directors 9. Committee memberships/ Nil chairmanships, if appointed 10. Independence declaration The appointee has confirmed that she meets the criteria of independence prescribed under applicable law. 11. Debarment confirmation The appointee is not debarred from holding the office of director by virtue of any SEBI order or order of any other authority. 12. Disqualification confirmation The appointee is not disqualified from holding office as a director under Section 164 of the Companies Act, 2013.